🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers market the drug there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.

Several experts stated the popularity for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Service Response and Material Elimination

Based on TikTok, the platform has removed violative content and prohibited associated keywords and search suggestions. The organization stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Online Trading Operations

Research also found groups with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.

Within moments of joining one group, a vendor posted contact information, where the majority of transactions occur. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.

Product Information and Costs

Within these groups, messages display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how much time a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they can’t verify. Although the science behind retatrutide is valid, these online products may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may subject patients to possibly serious health risks”.